Company Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa.
The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months.
It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners.
The company has a collaboration agreement with the University Hospitals Accountable Care Organization.
Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Country | United States |
IPO Date | Dec 22, 2015 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 132 |
CEO | Dr. Timothy T. Goodnow Ph.D. |
Contact Details
Address: 20451 Seneca Meadows Parkway Germantown, Maryland United States | |
Website | https://www.senseonics.com |
Stock Details
Ticker Symbol | SENS |
Exchange | AMEX |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001616543 |
CUSIP Number | 81727U105 |
ISIN Number | US81727U1051 |
Employer ID | 47-1210911 |
SIC Code | 3823 |
Key Executives
Name | Position |
---|---|
Dr. Timothy T. Goodnow Ph.D. | President, Chief Executive Officer & Director |
Dr. Mukul Jain Ph.D. | Chief Operating Officer |
Dr. Francine Ratner Kaufman M.D. | Chief Medical Officer & Director |
Kenneth L. Horton J.D. | General Counsel & Corporate Development Advisor |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 12, 2024 | 4 | Filing |
Dec 10, 2024 | 4 | Filing |
Dec 09, 2024 | DEFA14A | Filing |
Nov 29, 2024 | DEF 14A | Filing |
Nov 27, 2024 | S-3 | Filing |
Nov 19, 2024 | 8-K | Current Report |
Nov 19, 2024 | PRE 14A | Filing |
Nov 18, 2024 | 4 | Filing |
Nov 18, 2024 | 4 | Filing |
Nov 18, 2024 | 4 | Filing |